Perspectives: Rationale for combination therapies for choroidal neovascularization

American Journal of Ophthalmology

Volumn 141, Issue 1, 2006, Pages 149-156

  Spaide, Richard F ^a,b,c  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB; CORTICOSTEROID; PACLITAXEL; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; BLOOD VESSEL; CANCER; CANCER THERAPY; CATARACT; CELL STIMULATION; CLINICAL TRIAL; DRUG MECHANISM; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; GLIA CELL; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; INFLAMMATION; INFLAMMATORY CELL; INTRAOCULAR HYPERTENSION; MOLECULAR INTERACTION; PERICYTE; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SIDE EFFECT; STEM CELL; SUBRETINAL NEOVASCULARIZATION; TISSUE INJURY; UVEITIS; VASCULAR ENDOTHELIUM; VOLUMETRY; BIOLOGICAL MODEL; DRUG COMBINATION;

ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; HUMANS; MODELS, BIOLOGICAL;

EID: 29544436881     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.07.025     Document Type: Article

References (82)

1. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2004 2805 2816
2. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of two randomized clinical trials - TAP report 1 Arch Ophthalmol 117 1999 1329 1345
3. Verteporfin in Photodynamic Therapy Study Group Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 2001 541 560
4. R.F. Spaide, J. Sorenson, L. Maranan Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization Ophthalmology 112 2005 301 304
5. H.F. Dvorak, L.F. Brown, M. Detmar, A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1995 1029 1039
6. W.G. Roberts, G.E. Palade Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J Cell Sci 108 1995 2369 2379
7. S. Silletti, T. Kessler, J. Goldberg Disruption of matrix metalloproteinase 2 binding to alpha(v)beta3 by an organic molecule inhibits angiogenesis and tumor growth in vivo Proc Natl Acad Sci USA 98 2001 119 124
8. T. Asahara, H. Masuda, T. Takahashi Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221 228
9. D. Lyden, K. Hattori, S. Dias Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat Med 7 2001 1194 1201
10. K.K. Hirschi, S.A. Rohovsky, L.H. Beck, S.R. Smith, P.A. D'Amore Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact Circ Res 84 1999 298 305
11. D.C. Darland, L.J. Massingham, S.R. Smith Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival Dev Biol 264 2003 275 288
12. A. Abramsson, P. Lindblom, C. Betsholtz Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors J Clin Invest 112 2003 1142 1151
13. M.S. O'Reilly, T. Boehm, Y. Shing Endostatin an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
14. M.S. O'Reilly, L. Holmgren, Y. Shing Angiostatin a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
15. J. Marx Angiogenesis A boost for tumor starvation Science 301 2003 452 454
16. E. Marshall Cancer therapy Setbacks for endostatin Science 295 2002 2198 2199
17. L. Morbidelli, S. Donnini, F. Chillemi Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin Clin Cancer Res 9 2003 5358 5369
18. K.J. Kim, B. Li, J. Winer Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 1993 841 844
19. K.D. Miller, L.I. Chap, F.A. Holmes Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer J Clin Oncol 23 2005 792 799
20. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
21. M. Relf, S. LeJeune, P.A. Scott Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis Cancer Res 57 1997 963 969
22. T. Hampton Monoclonal antibody therapies shine in breast cancer clinical trials JAMA 293 2005 2985 2989
23. G. Bergers, S. Song, N. Meyer-Morse, E. Bergsland, D. Hanahan Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors J Clin Invest 111 2003 1287 1295
24. R. Erber, A. Thurnher, A.D. Katsen Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms FASEB J 18 2004 338 340
25. P. Carmeliet, R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
26. R.K. Jain Normalization of tumor vasculature an emerging concept in antiangiogenic therapy Science 307 2005 58 62
27. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 200;6:553-563.
28. R.J. Mayer Two steps forward in the treatment of colorectal cancer N Engl J Med 350 2004 2406 2408
29. G. Gasparini, R. Longo, M. Fanelli, B.A. Teicher Combination of antiangiogenic therapy with other anticancer therapies results, challenges, and open questions J Clin Oncol 23 2005 1295 1311
30. A. Abdollahi, K.E. Lipson, A. Sckell Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects Cancer Res 63 2003 8890 8898
31. H.E. Grossniklaus, W.R. Green Choroidal neovascularization Am J Ophthalmol 137 2004 496 503
32. H.E. Grossniklaus, J.X. Ling, T.M. Wallace Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization Mol Vis 8 2002 119 126
33. C. Tsutsumi-Miyahara, K.H. Sonoda, K. Egashira The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularization Br J Ophthalmol 88 2004 1217 1222
34. D.G. Espinosa-Heidmann, M.A. Reinoso, Y. Pina Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization Exp Eye Res 80 2005 369 378
35. M.C. Killingsworth Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 233 1995 313 323
36. H. Oh, H. Takagi, C. Takagi The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes Invest Ophthalmol Vis Sci 40 1999 1891 1898
37. C. Cursiefen, L. Chen, L.P. Borges VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J Clin Invest 113 2004 1040 1050
38. D.G. Espinosa-Heidmann, I.J. Suner, E.P. Hernandez Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization Invest Ophthalmol Vis Sci 44 2003 3586 3592
39. J. Ahmed, R.D. Braun, R. Dunn, R.A. Linsenmeier Oxygen distribution in the macaque retina Invest Ophthalmol Vis Sci 34 1993 516 521
40. R.F. Spaide Etiology of late-age-related macular disease F. Holz R.F. Spaide Medical Retina 2005 Springer-Verlag New York Holz F, Spaide RF, editors
41. D. Kent, C. Sheridan Choroidal neovascularization a wound healing perspective Mol Vis 9 2003 747 755
42. J.M. Rakic, V. Lambert, L. Devy Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization Invest Ophthalmol Vis Sci 44 2003 3186 3193
43. http://www.gene.com/gene/news/press-releases/display.do?method= detail&id=8447. Accessed June 25, 2005
44. N.N. Markomichelakis, P.G. Theodossiadis, P.P. Sfikakis Regression of neovascular age-related macular degeneration following infliximab therapy Am J Ophthalmol 139 2005 537 540
45. K. Hori, S. Saito, M. Tamai Effect of irradiation on neovascularization in rat skinfold chambers implications for clinical trials of low-dose radiotherapy for wet-type age-related macular degeneration Int J Radiat Oncol Biol Phys 60 2004 1564 1571
46. U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 2003 4473 4480
47. V.K. Gupta, N.T. Jaskowiak, M.A. Beckett Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance Cancer J 8 2002 47 54
48. P. Kermani, G. Leclerc, R. Martel, J. Fareh Effect of ionizing radiation on thymidine uptake, differentiation, and VEGFR2 receptor expression in endothelial cells the role of VEGF(165) Int J Radiat Oncol Biol Phys 50 2001 213 220
49. J. Brieger, P. Schroeder, J. Gosepath, W.J. Mann VEGF-subtype specific protection of SCC and HUVECs from radiation-induced cell death Int J Mol Med 15 2005 145 151
50. S. Boussat, S. Eddahibi, A. Coste Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells Am J Physiol Lung Cell Mol Physiol 279 2000 L371 L378
51. T. Ostendorf, U. Kunter, F. Eitner VEGF(165) mediates glomerular endothelial repair J Clin Invest 104 1999 913 923
52. D.J. D'Amico, M.F. Goldberg, H. Hudson Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration twelve-month clinical outcomes Ophthalmology 110 2003 2372 2383
53. S. Zucker, J. Cao, W.T. Chen Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment Oncogene 19 2000 6642 6650
54. T. Ishibashi, K. Miki, N. Sorgente Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate Arch Ophthalmol 103 1985 708 711
55. R.P. Danis, D.P. Bingaman, Y. Yang, B. Ladd Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide Ophthalmology 103 1996 2099 2104
56. A.N. Antoszyk, J.L. Gottlieb, R. Machemer, D.L. Hatchell The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization Graefes Arch Clin Exp Ophthalmol 231 1993 34 40
57. M. Nauck, G. Karakiulakis, A.P. Perruchoud Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells Eur J Pharmacol 341 1998 309 315
58. S. Matsuda, F. Gomi, Y. Oshima Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress Invest Ophthalmol Vis Sci 46 2005 1062 1068
59. H. Itaya, T. Imaizumi, H. Yoshida Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide Thromb Haemost 85 2001 171 176
60. Y.H. Li, A. Brauner, J.S. Jensen, K. Tullus Induction of human macrophage vascular endothelial growth factor and intercellular adhesion molecule-1 by ureaplasma urealyticum and downregulation by steroids Biol Neonate 82 2002 22 28
61. H.L. Brooks Jr, S. Caballero Jr, C.K. Newell Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone Arch Ophthalmol 122 2004 1801 1807
62. T.A. Ciulla, M.H. Criswell, R.P. Danis, T.E. Hill Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model Arch Ophthalmol 119 2001 399 404
63. M.R. Castro, D. Lutz, J.L. Edelman Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization Exp Eye Res 79 2004 275 285
64. J.L. Edelman, M.R. Castro, Y. Wen Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea Invest Ophthalmol Vis Sci 40 1999 1112 1123
65. J.L. Edelman, D. Lutz, M.R. Castro Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown Exp Eye Res 80 2005 249 258
66. U.H. Spandau, G. Sauder, U. Schubert Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo Br J Ophthalmol 89 2005 745 747
67. Y.S. Wang, U. Friedrichs, W. Eichler Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells Graefes Arch Clin Exp Ophthalmol 240 2002 42 48
68. U. Bolkenius, D. Hahn, A.M. Gressner Glucocorticoids decrease the bioavailability of TGF-β which leads to a reduced TGF-beta signaling in hepatic stellate cells Biochem Biophys Res Commun 325 2004 1264 1270
69. H. Tamura, K. Miyamoto, J. Kiryu Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina Invest Ophthalmol Vis Sci 46 2005 1440 1444
70. P.L. Penfold, L. Wen, M.C. Madigan Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line implications for macular degeneration Clin Exp Immunol 121 2000 458 465
71. P.L. Penfold, L. Wen, M.C. Madigan Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells Invest Ophthalmol Vis Sci 43 2002 3125 3130
72. B.S. Kang, E.Y. Chung, Y.P. Yun Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity Biol Pharm Bull 24 2001 701 703
73. L.M. Breuninger, W.L. Dempsey, J. Uhl, D.M. Murasko Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes Clin Immunol Immunopathol 69 1993 205 214
74. D.A. Antonetti, E.B. Wolpert, L. DeMaio Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin J Neurochem 80 2002 667 677
75. P.L. Penfold, J.F. Gyory, A.B. Hunyor, F.A. Billson Exudative macular degeneration and intravitreal triamcinolone A pilot study Aust N Z J Ophthalmol 23 1995 293 298
76. J.K. Challa, M.C. Gillies, P.L. Penfold Exudative macular degeneration and intravitreal triamcinolone 18 month follow up Aust N Z J Ophthalmol 26 1998 277 281
77. R.P. Danis, T.A. Ciulla, L.M. Pratt, W. Anliker Intravitreal triamcinolone acetonide in exudative age-related macular degeneration Retina 20 2000 244 250
78. M.C. Gillies, J.M. Simpson, W. Luo A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results Arch Ophthalmol 121 2003 667 773
79. J.B. Jonas, I. Kreissig, P. Hugger Intravitreal triamcinolone acetonide for exudative age related macular degeneration Br J Ophthalmol 87 2003 462 468
80. G. Gasparini Metronomic scheduling the future of chemotherapy? Lancet Oncol 2 2001 733 740
81. T. Tammela, B. Enholm, K. Alitalo, K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res 15 65 2005 550 563
82. P. Baluk, H. Hashizume, D.M. McDonald Cellular abnormalities of blood vessels as targets in cancer Curr Opin Genet Dev 15 2005 102 111